Left Bundle Branch Area Pacing (LBBAP) PMCF Study
NCT: NCT07217392 · RECRUITING
Brief Summary
The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.
Frequently Asked Questions
What is Left Bundle Branch Area Pacing (LBBAP) PMCF Study?
Left Bundle Branch Area Pacing (LBBAP) PMCF Study is a clinical trial registered under NCT07217392. Current status: RECRUITING.
What is the status of NCT07217392?
The current status of NCT07217392 (Left Bundle Branch Area Pacing (LBBAP) PMCF Study) is: RECRUITING.
When did Left Bundle Branch Area Pacing (LBBAP) PMCF Study start?
Left Bundle Branch Area Pacing (LBBAP) PMCF Study started on 2025-07-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.